Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling
- PMID: 18707092
- DOI: 10.1021/ci800041k
Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling
Abstract
Recently, the worldwide spread of A/H5N1 avian influenza with high virulence has highlighted the potential threat of human influenza pandemic. Tamiflu and Relenza are currently the only two anti-influenza drugs targeting the neuraminidase (NA) enzyme of human influenza virus. Reports of the emergence of drug resistance further make the development of new potent anti-influenza inhibitors a priority. The X-ray crystallographic study of A/H5N1 avian influenza NA subtypes (Russell, R. J. Nature 2006, 443, 45-49) has demonstrated that there exist two genetically distinct groups, group-1 (N1, N4, N5 and N8) and group-2 (N2, N3, N6, N7 and N9), whose conformations are substantially different. The detailed comparison of their active sites has established, heretofore, the most accurate and solid molecular basis of structure and mechanism for the development of new anti-influenza drugs. In the present study, a three-dimensional structure of N1 subtype of human influenza type A virus (N1hA) has been generated by homology modeling using the X-ray crystallographic structure of N1 subtype of avian influenza virus (N1aA) as the template. Binding interaction analysis between the active site and its inhibitors has been performed by combining ab initio fragment molecular orbital (FMO) calculations and three-dimensional quantitative structure-activity relationship with comparative molecular field analysis (3D-QSAR CoMFA) modeling. Integrated with docking-based 3D-QSAR CoMFA modeling, molecular surface property (electrostatic and steric) mapping and FMO pair interaction analysis, a set of new receptor-ligand binding models and bioaffinity predictive models for rational design and virtual screening of more potent inhibitors of N1hA are established. In addition, the flexibility of the loop-150 of N1hA and N1aA has been examined by a series of molecular dynamics simulations.
Similar articles
-
On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).Biophys Chem. 2009 Mar;140(1-3):35-8. doi: 10.1016/j.bpc.2008.11.004. Epub 2008 Nov 20. Biophys Chem. 2009. PMID: 19117662
-
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. doi: 10.1016/j.bbrc.2007.08.025. Epub 2007 Aug 13. Biochem Biophys Res Commun. 2007. PMID: 17707775
-
Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.J Comb Chem. 2007 Jan-Feb;9(1):131-8. doi: 10.1021/cc060101e. J Comb Chem. 2007. PMID: 17206841
-
Avian influenza virus, a very sticky situation.Curr Opin Chem Biol. 2008 Feb;12(1):102-8. doi: 10.1016/j.cbpa.2008.01.036. Epub 2008 Mar 11. Curr Opin Chem Biol. 2008. PMID: 18295610 Review.
-
Anti-influenza drugs: the development of sialidase inhibitors.Handb Exp Pharmacol. 2009;(189):111-54. doi: 10.1007/978-3-540-79086-0_5. Handb Exp Pharmacol. 2009. PMID: 19048199 Review.
Cited by
-
Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine.PLoS Comput Biol. 2011 Dec;7(12):e1002315. doi: 10.1371/journal.pcbi.1002315. Epub 2011 Dec 22. PLoS Comput Biol. 2011. PMID: 22215997 Free PMC article.
-
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.Antimicrob Agents Chemother. 2009 Mar;53(3):1039-47. doi: 10.1128/AAC.01446-08. Epub 2009 Jan 5. Antimicrob Agents Chemother. 2009. PMID: 19124660 Free PMC article.
-
Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening.J Mol Model. 2011 Jun;17(6):1483-92. doi: 10.1007/s00894-010-0847-9. Epub 2010 Sep 23. J Mol Model. 2011. PMID: 20862594
-
Virtual interactomics of proteins from biochemical standpoint.Mol Biol Int. 2012;2012:976385. doi: 10.1155/2012/976385. Epub 2012 Aug 8. Mol Biol Int. 2012. PMID: 22928109 Free PMC article.
-
2D-SAR, Topomer CoMFA and molecular docking studies on avian influenza neuraminidase inhibitors.Comput Struct Biotechnol J. 2018 Dec 7;17:39-48. doi: 10.1016/j.csbj.2018.11.007. eCollection 2019. Comput Struct Biotechnol J. 2018. PMID: 30595814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical